Electronic Symptom Monitoring Intervention for Hospitalized Patients With Cancer
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Cancer
- Sponsor
- Massachusetts General Hospital
- Enrollment
- 390
- Locations
- 1
- Primary Endpoint
- Proportion of days with improved symptoms between study arms
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
This research study is evaluating a new way to deliver oncology care for patients with cancer
Detailed Description
Patients with cancer may experience a considerable symptom burden, often requiring hospitalizations for symptom management. The study doctors want to know if daily electronic monitoring of the symptoms, such as pain, nausea, constipation, and diarrhea may improve care while participants are hospitalized. The goal of this study is to evaluate a new way to deliver oncology care where patients' symptoms are systematically monitored during their hospital admission. The investigators are studying whether patients whose clinicians receive their patients' detailed symptom reports each day have improved symptom management compared to those whose clinicians do not receive their patients' detailed symptom reports each day. The study will use questionnaires to measure the participant symptoms and involves participating in a study for as long as the participants are admitted to the hospital. The information the investigators collect will help them determine if electronic symptom monitoring improves the care of patients with cancer
Investigators
Ryan Nipp
Principal Investigator
Massachusetts General Hospital
Eligibility Criteria
Inclusion Criteria
- •Age 18 or older
- •Diagnosed with advanced cancer (defined as receiving treatment with palliative intent as per chemotherapy order entry designation, oncology clinic notes, and/or trial consent forms, or not receiving chemotherapy but followed for incurable disease as per oncology clinic notes)
- •Admitted to the oncology service at Massachusetts General Hospital
- •Verbal fluency in English
Exclusion Criteria
- •Unwilling or unable to participate in the study
- •Admitted electively
- •Participated during a previous admission
Outcomes
Primary Outcomes
Proportion of days with improved symptoms between study arms
Time Frame: 2 years
Using ESAS and PHQ symptoms, the investigators will compare the proportion of days that symptoms improved in standard care versus IMPROVED.
Secondary Outcomes
- Proportion of days with worsened symptoms between study arms(2 years)
- Hospital readmissions within 90 days of prior hospital discharge between study arms(90 days)
- Change in patients' symptom scores from baseline to discharge(2 years)
- Hospital readmissions within 30 days of prior hospital discharge between study arms(30 days)
- Hospital length of stay (measured continuously as days admitted to the hospital) between study arms(2 years)